M67.272
Synovial hypertrophy, not elsewhere classified, left ankle and foot
Clinical Classification Guidelines
Medical Intelligence & Overview
Synovial hypertrophy refers to the abnormal thickening of the synovial membrane, the lining of the joint capsule, due to inflammation or other pathological processes. When this condition affects the left ankle and foot, it can cause discomfort, swelling, and reduced mobility. This guide provides a comprehensive overview of synovial hypertrophy classified under ICD-10 code M67.272, focusing on its causes, symptoms, diagnosis, and management approaches.
Causes & Symptoms
Clinical Causes: Chronic joint inflammation such as that seen in conditions like rheumatoid arthritis Repetitive trauma or overuse injuries to the ankle and foot Degenerative joint diseases, including osteoarthritis Infections affecting the joint space Reaction to previous joint surgery or injury Autoimmune disorders leading to joint inflammation Other inflammatory or proliferative joint conditions
Key Symptoms: Swelling and puffiness around the ankle and foot Persistent pain or tenderness in the affected area Stiffness, particularly after periods of inactivity Limited range of motion in the ankle and foot joints Warmth and redness over the joint area A sensation of fluid buildup or heaviness Possible squeaking or crepitus during movement
Diagnostic & Treatment
Diagnosis Path: Diagnosing synovial hypertrophy involves a combination of clinical assessment and imaging studies. The healthcare professional may perform a physical examination to evaluate swelling, tenderness, and joint function. Imaging tests such as ultrasound can detect thickening of the synovial membrane and joint effusion. Magnetic resonance imaging (MRI) provides detailed visualization of soft tissues, confirming the extent of hypertrophy and ruling out other joint pathologies. In some cases, joint aspiration may be performed to analyze synovial fluid for infection or crystal-induced arthritis.
Treatment Protocols: Management of synovial hypertrophy focuses on reducing inflammation, alleviating symptoms, and improving joint function. Common approaches include: - Anti-inflammatory medications such as NSAIDs to decrease swelling and pain - Physical therapy to maintain joint mobility and strengthen surrounding muscles - Rest and activity modification to prevent aggravation - Corticosteroid injections directly into the joint for short-term relief - Surgical intervention in cases where conservative measures fail, which may involve synovectomy (removal of hypertrophied synovial tissue) - Addressing underlying causes, such as managing rheumatoid arthritis or degenerative joint disease It is essential to consult with healthcare professionals for personalized diagnosis and treatment planning.
Clinical Advice & FAQs
Billing Guidance
Is M67.272 a billable ICD-10 code?
Yes, M67.272 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M67.272?
Clinical documentation must specify the nature of Synovial hypertrophy, not elsewhere classified, left ankle and foot and any associated comorbidities for accurate reporting.
Cite this Clinical Reference